Cutter & CO Brokerage, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Cutter & CO Brokerage, Inc.

$406 Million
Q3 2024

A detailed history of Cutter & CO Brokerage, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 7,665 shares of REGN stock, worth $5.21 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares

7,665

Previous 7,776 1.43%

Holding current value

$5.21 Million

Previous $8.17 Million 1.41%

% of portfolio

1.98%

Previous 2.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $113,673 - $133,395	-111 Reduced 1.43%	7,665 $8.06 Million
Q2 2024 Jul 31, 2024	SELL	$883.2 - $1071.19 $44,160 - $53,559	-50 Reduced 0.64%	7,776 $8.17 Million
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $51,453 - $56,620	-57 Reduced 0.72%	7,826 $7.53 Million
Q4 2023 Feb 01, 2024	SELL	$775.18 - $881.7 $142,633 - $162,232	-184 Reduced 2.28%	7,883 $6.92 Million
Q3 2023 Oct 31, 2023	SELL	$692.45 - $844.37 $37,392 - $45,595	-54 Reduced 0.66%	8,067 $6.64 Million
Q2 2023 Aug 01, 2023	SELL	$700.03 - $830.35 $14,000 - $16,607	-20 Reduced 0.25%	8,121 $5.84 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $38,787 - $47,137	-57 Reduced 0.7%	8,141 $6.69 Million
Q4 2022 Feb 03, 2023	SELL	$705.89 - $766.39 $300,003 - $325,715	-425 Reduced 4.93%	8,198 $5.91 Million
Q3 2022 Nov 03, 2022	SELL	$573.97 - $724.32 $139,474 - $176,009	-243 Reduced 2.74%	8,623 $5.94 Million
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $10,967 - $14,776	-20 Reduced 0.23%	8,866 $5.24 Million
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $12,497 - $14,667	-21 Reduced 0.24%	8,886 $6.21 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $838,589 - $1.04 Million	1,543 Added 20.95%	8,907 $5.63 Million
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $516,627 - $612,864	900 Added 13.92%	7,364 $4.46 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $33,096 - $39,097	-70 Reduced 1.07%	6,464 $3.61 Million
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $425,286 - $521,886	952 Added 17.05%	6,534 $3.09 Million
Q4 2020 Feb 03, 2021	SELL	$478.3 - $607.98 $43,047 - $54,718	-90 Reduced 1.59%	5,582 $2.7 Million
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $29,961 - $36,201	-55 Reduced 0.96%	5,672 $3.18 Million
Q2 2020 Aug 10, 2020	SELL	$493.32 - $643.92 $36,999 - $48,294	-75 Reduced 1.29%	5,727 $3.57 Million
Q1 2020 May 05, 2020	BUY	$336.18 - $494.43 $55,469 - $81,580	165 Added 2.93%	5,802 $2.83 Million
Q4 2019 Feb 11, 2020	BUY	$274.13 - $376.51 $13,706 - $18,825	50 Added 0.89%	5,637 $2.12 Million
Q3 2019 Nov 07, 2019	BUY	$273.46 - $318.39 $30,900 - $35,978	113 Added 2.06%	5,587 $1.55 Million
Q2 2019 Jul 31, 2019	BUY	$299.6 - $414.82 $71,304 - $98,727	238 Added 4.55%	5,474 $1.71 Million
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $253,544 - $304,295	755 Added 16.85%	5,236 $1.96 Million
Q3 2018 Oct 12, 2018	BUY	$351.14 - $408.51 $13,343 - $15,523	38 Added 0.86%	4,481 $1.81 Million
Q2 2018 Jul 30, 2018	BUY	$284.6 - $344.99 $1.26 Million - $1.53 Million	4,443 New	4,443 $1.53 Million

Others Institutions Holding REGN

# of Institutions

1,509

Shares Held

82.7M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.

Account

Cutter & CO Brokerage, Inc. Regeneron Pharmaceuticals, Inc. Transaction History